Home » Germany: Gilde Healthcare sells RAD-x to Swiss Life and Vesper AM

Germany: Gilde Healthcare sells RAD-x to Swiss Life and Vesper AM

Germany: Gilde Healthcare sells RAD-x to Swiss Life and Vesper AM

Swiss Life Asset Managers and Vesper Next Generation Infrastructure Fund I have agreed to acquire RAD-x from specialized healthcare investor Gilde Healthcare’s Private Equity Fund. RAD-x is one of the leading diagnostic imaging providers in Germany and Switzerland.

The investment will enable RAD-x to expand its geographic reach while developing and enhancing its product offering to provide essential, high quality and accessible health care infrastructure services.

Gilde Healthcare invested in and, together with the founders, set-up RAD-x in 2016. Since then, RAD-x has grown into one of the largest diagnostic imaging platforms in the region, with 23 centres across Germany and Switzerland, more than 130 doctors and 750 staff. It performs more than 400,000 examinations annually.

RAD-X is one of the main market consolidators and remains well positioned to further broaden its radiology platform across Europe under the new ownership. The consortium will support RAD-x’s growth ambitions through a significant growth plan aimed at expanding its current footprint in its existing as well as new markets. The transaction is subject to customary regulatory approvals and is expected to close mid 2024.

“We continue to see powerful sector tailwinds within the diagnostics space, driven by an aging population and an increasing importance of preventive diagnostics,” said Gianfranco Saladino, head Value-Add Infrastructure at Swiss Life Asset Managers.

Advisors

Lincoln International (M&A), EY (financial and tax), Willkie Farr & Gallagher (tax), L.E.K. Consulting (commercial), LUPP+Partner (legal), Ebner Stolz (legal) and Dentons France (legal) have been acting as advisors to Gilde Healthcare.